Apellis Pharmaceuticals, Inc. (APLS)
40.41
+0.02
(+0.05%)
USD |
NASDAQ |
Apr 02, 16:00
40.37
-0.04
(-0.10%)
After-Hours: 20:00
Apellis Pharmaceuticals EPS Diluted (Quarterly) : -0.4654 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Biogen, Inc. | -0.3333 |
| Eli Lilly & Co. | 7.024 |
| Agios Pharmaceuticals, Inc. | -1.852 |
| Scholar Rock Holding Corp. | -0.8824 |
| BridgeBio Pharma, Inc. | -0.9964 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -58.95M |
| Revenue (Quarterly) | 199.91M |
| Total Expenses (Quarterly) | 258.86M |
| Enterprise Value | 5.172B |
| Gross Profit Margin (Quarterly) | 85.13% |
| Profit Margin (Quarterly) | -29.49% |
| Earnings Yield | 0.31% |
| Operating Earnings Yield | 1.08% |
| Normalized Earnings Yield | 0.3056 |